Zuidland, NETHERLANDS – DORC International and WEFIS GmbH are excited to announce a strategic partnership, based on an equity investment by DORC. The partnership will focus on research and development to deliver innovation in performance, efficiency and usability of instruments for cataract surgery.
This strategic partnership and investment will ensure close collaboration between the respective research and developments teams at DORC and WEFIS.
- This initiative will strengthen DORC’s commitment and investment in the cataract surgical market.
- WEFIS have been a supplier to DORC since 2003 for cataract surgical products and a business partner for DORC in Germany since 2008.
- Together WEFIS and DORC have a long history of innovation in the field.
- The partnership will focus on innovation in cataract surgical products for use with the EVA platform and EQUIPHACO range of disposables for improved performance in cataract surgery.
- Partnership is based on an undisclosed equity investment by DORC International.
- Existing WEFIS supplier relationships with other companies will be unaffected by this partnership as well as WEFIS customer relationships in the German market.
- 2022 will see a series of further innovation announcements from DORC in the field of cataract surgery.
Commenting on the partnership, Pierre Billardon, CEO, DORC International, welcomed the news: “WEFIS and DORC share a history of innovation in ophthalmic surgery, this partnership will transform our existing supplier relationship to deliver an exciting range of future innovation for retina and cataract surgeons worldwide”.
“DORC are a market leader in retina surgery and WEFIS have a long track record of bringing innovation to cataract surgery, this partnership definitely brings both companies a wealth of opportunities in the dual cataract and retina surgery market ” - commented Dietrich Wernz, CEO WEFIS. “All the team at WEFIS are excited about the potential for a closer future collaboration whilst remaining committed to excellence in meeting the needs of our existing industry customers”.
For editorial or corporate comment please contact:
Sandra Janmaat email@example.com
About DORC International
For more than 30 years D.O.R.C. Dutch Ophthalmic Research Center (International) B.V. has worked intensively with leading top surgeons. Therefore at D.O.R.C. we know exactly which requirements instruments and equipment must satisfy. Our knowledge, combined with a unique mix of talent for the development of new ideas, high design quality and a strong product philosophy, results in highly innovative products. DORC is recognized as global market leader in anterior surgery dyes with Vision Blue, the one and only FDA-approved stain for cataract surgery plus a broad range of instruments for anterior surgery.
The clients, surgeons from all four corners of the earth are D.O.R.C.'s focal point. Our approach is both personal and professional. We do everything possible to realize innovative and affordable solutions. And all of our efforts are subject to high ethical and moral standards. That is why, in close collaboration with the physicians, we continuously subject our procedures and products to rigorous evaluations.
D.O.R.C. Dutch Ophthalmic Research Center (International) B.V. exports its instruments and equipment to more than eighty countries worldwide and has its own sales and marketing organizations in Austria, Belgium, China, Finland, France, Germany, Italy, the Netherlands, Norway, Spain, Sweden, UK, USA. For further information : www.dorcglobal.com
About WEFIS GmbH
WEFIS GmbH has been developing, producing and distributing instruments for ophthalmic surgery since 1998. The focus is on products used in cataract and vitreoretinal surgery. The headquarters of our company has been located in Cologne since its foundation. Our development and production departments are located in Westerburg.
WEFIS is a pioneer in the field of cataract instruments with the Phaco Lite Technology handpiece in terms of handling, performance and compactness. Efficiency, quality and innovation are the core corporate values by which we have been operating for over 20 years. They are the quality promise to
our customers to experience the complete service of the WEFIS brand. Patients and users deserve to receive products of the highest quality and safety.
As the basis for our success, our corporate strategy focuses on achieving technological progress through continuous development of our products. Our many years of experience, the intensive cooperation with internationally and recognized ophthalmologists as well as the cooperation with our worldwide distributors form the basis for our high quality standards. The decisive factors of our success concept are our motivated employees, a well-developed service system and the innovative strength of our company.